The histamine H4 receptor as a new therapeutic target for inflammation.
about
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptorsNeuroendocrine immunoregulation in multiple sclerosisH4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cellsLuciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: correlations and discrepancies between distal and proximal readoutsInteractions between histamine H3 and dopamine D2 receptors and the implications for striatal functionHistamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation.Genetic Analysis of Histamine Signaling in Larval Zebrafish Sleep.Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degenerationDeletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression.Histamine receptors and cancer pharmacology.The role of histamine H4 receptor in immune and inflammatory disordersDistinct signalling pathways of murine histamine H1- and H4-receptors expressed at comparable levels in HEK293 cells.In vivo responses of cutaneous C-mechanosensitive neurons in mouse to punctate chemical stimuli that elicit itch and nociceptive sensations in humansGenetic Variation in the Histamine Production, Response, and Degradation Pathway Is Associated with Histamine Pharmacodynamic Response in Children with Asthma.Sequential engagement of FcεRI on Mast Cells and Basophil Histamine H(4) Receptor and FcεRI in Allergic Rhinitis.Histamine modulates microglia functionHistamine-HisCl1 receptor axis regulates wake-promoting signals in Drosophila melanogasterTherapeutic potential of histamine H₄ receptor agonists in triple-negative human breast cancer experimental model.Molecular and biochemical pharmacology of the histamine H4 receptor.Understanding the pathophysiology of itchHistamine and histamine receptor regulation of gastrointestinal cancers.The histamine H4 receptor is a potent inhibitor of adhesion-dependent degranulation in human neutrophils.Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430.The histamine H4 receptor is functionally expressed on neurons in the mammalian CNSEffects of sympathetic histamine on vasomotor responses of blood vessels in rabbit ear to electrical stimulation.Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivativesDevelopment of time-resolved fluorescent based [EU]-GTP binding assay for selection of human Histamine 3 receptor antagonists/inverse agonist: a potential target for Alzheimer's treatment.Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants.Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands.Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H3 and H4 Receptors with Anti-inflammatory Potential.Histamine activates inflammatory response and depresses casein synthesis in mammary gland of dairy cows during SARA.Are Polyunsaturated Fatty Acids Implicated in Histaminergic Dysregulation in Bipolar Disorder?: AN HYPOTHESIS.The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets
P2860
Q24644889-A86A8C93-741E-4F8B-B178-65DDA0757029Q26864449-9CEC1B05-30BA-45BC-9320-FF33A83BEA5DQ28475930-D6208DA7-AC43-4B75-B795-04DA293F24C2Q28536518-898EF2B3-8A70-4014-A31B-7AEFAAB6E5BFQ28757876-8F1D5480-B5B0-4BE1-916C-1C246E4E6BB9Q30276672-E53751B6-CF30-4639-A734-FD367CACFCCAQ30361534-C32D4727-BCB6-40CC-88D1-8FE5E0139026Q34025192-C325F380-7183-4095-A4A3-BC79E7D36440Q34170633-F5EF9E17-940A-4EFB-8897-208CA173A331Q34356076-FBAF7F6C-0D76-474C-991A-8E987D42C9CCQ34967790-2EE706C6-351F-489C-BF66-6C952BC357BFQ35268844-037D54BA-0184-47A8-B278-D6F1B0274E5AQ35951440-9658CF95-E112-43F2-8B5D-93E4512A8AFDQ36253417-744D919C-D3CC-4F76-9034-950C2BBBA73DQ36514092-E2B0327C-EDEF-47C3-921F-8E1FBA789F2AQ36641315-D046C765-C85F-488B-A013-1CFBD1AEFF16Q36981092-9895C9D5-B489-41DB-9E82-6865AFE6EB8DQ37151169-49F3F6F7-2110-4205-9EDE-C1E42F38C238Q37469102-FC28A4DF-5F08-44D5-81B4-B578EABFF035Q38095597-6339B9C5-1DC9-409B-9D98-E0226199F73EQ38196813-0075C102-9CEA-4EE8-A5D8-A9C3540BE00AQ38998092-E1E83F4E-A7C3-4A92-AD8C-DBCF4E79AA61Q39857276-5D4E6E7A-4BB5-48EC-ADB6-168CF40C650AQ41420104-7990D3AC-A7CE-46A0-A879-5DD03E84B1BEQ41441953-2052B190-FDD7-4D5B-9564-615FE1249E77Q41888634-D9ED1A95-6101-4F98-8073-C5054AE1DF1EQ42465337-30098052-82B1-4222-AF32-4495A3B03579Q42554178-9BB754CC-C6F9-466D-9F07-13B0801DF53DQ42727402-9031F2DE-0CF6-4309-9AA8-38881F9AA34FQ42921406-4D43420D-EDC1-4FB3-9192-9B8650AA6A29Q47102892-39591968-DF86-49B6-90F1-5F1436B83B25Q54978433-4D19C1E2-C1DC-48CD-8B51-A404B14430BEQ55315268-9B819820-06CD-4D39-8D9D-772864D0EEC9Q58785720-D75450CE-C68D-4947-88E2-333BABBE5E6A
P2860
The histamine H4 receptor as a new therapeutic target for inflammation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The histamine H4 receptor as a new therapeutic target for inflammation.
@ast
The histamine H4 receptor as a new therapeutic target for inflammation.
@en
type
label
The histamine H4 receptor as a new therapeutic target for inflammation.
@ast
The histamine H4 receptor as a new therapeutic target for inflammation.
@en
prefLabel
The histamine H4 receptor as a new therapeutic target for inflammation.
@ast
The histamine H4 receptor as a new therapeutic target for inflammation.
@en
P2093
P1476
The histamine H4 receptor as a new therapeutic target for inflammation.
@en
P2093
Aldo Jongejan
Iwan J P de Esch
P304
P356
10.1016/J.TIPS.2005.07.002
P577
2005-09-01T00:00:00Z